Insights

Gathering insights about Avara…

Similar companies to Avara

Avara Tech Stack

Avara uses 8 technology products and services including Grafana, Blockchain, Google Font API, and more. Explore Avara's tech stack below.

Grafana
Analytics
Blockchain
Blockchain
Google Font API
Font Scripts
Open Graph
Miscellaneous
LottieFiles
Miscellaneous
Vercel
Platform As A Service
JavaScript
Programming Languages
HSTS
Security

Media & News

Savara Announces Participation in the Leerink Global Healthcare Conference
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that members of its management team will attend the Leerink Global Healthcare Conference and participate in a fireside chat on Tuesday, March 11th, 10:40am ET/7:40am PT. The live webcast and subsequent replay will be available on the “Events & Presentations” section of the Company's corporate website at https://savaraphar.
Mar 03, 2025 | www.businesswire.com
Savara Announces New Employment Inducement Grant
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to five new employees. On February 12, 2025, the Compensation Committee of Savara's Board of Directors granted the inducement awards to five new employees who recently joined the Company. The inducement awards consist of options to purchase an aggregate of 97,500 shares of the Company's common stock and restr.
Feb 14, 2025 | www.businesswire.com
Savara Announces Manuscript on Long-Term Outcomes With Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Published in ERJ Open Research
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced a manuscript titled, “Long-Term Outcomes in Five Patients with Autoimmune Pulmonary Alveolar Proteinosis Treated with Molgramostim Inhalation Solution" was published online in the journal ERJ Open Research. The outcomes data presented suggest that treatment with molgramostim addresses the underlying pathophysiology of aPAP, r.
Jan 30, 2025 | www.businesswire.com
Savara Announces New Employment Inducement Grant
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to five new employees. On December 20, 2024, the Compensation Committee of Savara's Board of Directors granted the inducement awards to five new employees who recently joined the Company. The inducement awards consist of options to purchase an aggregate of 100,000 shares of the Company's common stock and rest.
Dec 23, 2024 | www.businesswire.com
Savara Initiates Rolling Submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, initiated a rolling submission of a BLA to the FDA for MOLBREEVI for the potential treatment of aPAP, a chronic and debilitating rare lung disease characterized by the abnormal build-up of surfactant in the alveoli of the lungs. MOLBREEVI was granted Fast Track and Breakthrough Therapy Designations in 2019 for the treatment of patients with.
Dec 18, 2024 | www.businesswire.com
Savara Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that the Company will present and host 1x1 meetings at the 43rd Annual J.P. Morgan Healthcare Conference. Date/Time of Presentation: January 15, 5:15pm PT/8:15pm ET Presenter: Matt Pauls, Chair and Chief Executive Officer, Savara Location: Westin St. Francis, San Francisco, Elizabethan C Room The live webcast and subsequent r.
Dec 17, 2024 | www.businesswire.com
Savara Announces New Employment Inducement Grant
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to four new employees. On November 20, 2024, the Compensation Committee of Savara's Board of Directors granted the inducement awards to four new employees who recently joined the Company. The inducement awards consist of options to purchase an aggregate of 80,000 shares of the Company's common stock and restr.
Nov 22, 2024 | www.businesswire.com

Avara's Email Address Formats

Avara uses at least 2 format(s):

Avara Email Formats	Example	Percentage
First@aave.com	John@aave.com	75%
First.L@aave.com	John.D@aave.com	9%
Last@aave.com	Doe@aave.com	4%
FirLast@aave.com	JohDoe@aave.com	4%
First.Last@aave.com	John.Doe@aave.com	2%
FLast@aave.com	JDoe@aave.com	1%
LastF@aave.com	DoeJ@aave.com	2%
First_Last@aave.com	John_Doe@aave.com	1%
F.Last@aave.com	J.Doe@aave.com	1%
FirstL@aave.com	JohnD@aave.com	1%
First@avara.xyz	John@avara.xyz	100%

Frequently Asked Questions

Where is Avara's headquarters located?

Avara's main headquarters is located at 9 Pembridge Road London, England W11 3JY GB. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is Avara's stock symbol?

Avara is a publicly traded company; the company's stock symbol is SVRA.

What is Avara's official website and social media links?

Avara's official website is avara.xyz and has social profiles on LinkedIn.

How much revenue does Avara generate?

As of December 2024, Avara's annual revenue reached $35M.

What is Avara's NAICS code?

Avara's NAICS code is 5415 - Computer Systems Design and Related Services.

How many employees does Avara have currently?

As of December 2024, Avara has approximately 130 employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Compliance Officer: N. B.Chief Financial Officer: P. K.Chief Design Officer: R. V. G.. Explore Avara's employee directory with LeadIQ.

What industry does Avara belong to?

Avara operates in the IT Services and IT Consulting industry.

What technology does Avara use?

Avara's tech stack includes GrafanaBlockchainGoogle Font APIOpen GraphLottieFilesVercelJavaScriptHSTS.

What is Avara's email format?

Avara's email format typically follows the pattern of . Find more Avara email formats with LeadIQ.

When was Avara founded?

Avara was founded in 2017.

Avara

IT Services and IT ConsultingEngland, United Kingdom51-200 Employees

Avara is a software technology company, renowned for building innovative web3 products based on blockchain technologies. Founded by Stani Kulechov, we’ve developed the battle tested Aave Protocol, the Aave-native stablecoin GHO, and Lens, the decentralized social networking protocol. With strategic acquisitions including the metaverse app, Sonar, and Family crypto wallet, Avara is dedicated to realizing a people-powered internet that benefits everyone. Learn more at avara.xyz.

Company Overview

Headquarters: 9 Pembridge Road London, England W11 3JY GB
Website: avara.xyz
Stock Symbol: SVRA
NAICS Code: 5415 - Computer Systems Design and Related Services
Founded: 2017
Employees: 51-200

Media & News

Funding & Financials

$10M$50M
Avara's revenue is in the range of $10M$50M

Funding & Financials

$10M$50M
Avara's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Avara

Coinbase

Gemini

Crypto.com

Bitfinex

eToro

Revolut

Kraken

Nexo

BlockFi

Uphold

Voyager

Binance

Celsius

Avara Tech Stack

Media & News

Savara Announces Participation in the Leerink Global Healthcare Conference

Savara Announces New Employment Inducement Grant

Savara Announces Manuscript on Long-Term Outcomes With Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Published in ERJ Open Research

Savara Announces New Employment Inducement Grant

Savara Initiates Rolling Submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Savara Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Savara Announces New Employment Inducement Grant

Avara's Email Address Formats

Frequently Asked Questions

Where is Avara's headquarters located?

What is Avara's stock symbol?

What is Avara's official website and social media links?

How much revenue does Avara generate?

What is Avara's NAICS code?

How many employees does Avara have currently?

What industry does Avara belong to?

What technology does Avara use?

What is Avara's email format?

When was Avara founded?

Avara

Company Overview

Media & News

Savara Announces Participation in the Leerink Global Healthcare Conference

Savara Announces New Employment Inducement Grant

Savara Announces Manuscript on Long-Term Outcomes With Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Published in ERJ Open Research

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?